References
- Krasavin M. Novel diversely substituted 1-heteroaryl-2-imidazolines for fragment-based drug discovery. Tetrahedron Lett 2012;53:2876–80
- Krasavin M. Biologically active compounds based on the privileged 2-imidazoline scaffold: the world beyond adrenergic/imidazoline receptor modulators. Eur J Med Chem 2015;97:525–37
- Krasavin M. Pd-catalyzed N-arylation of 2-imidazolines provides convenient access to selective cyclooxygenase-2 inhibitors. Lett Org Chem 2013;10:235–9
- Sarnpitak P, Mujumdar P, Morisseau C, et al. Potent, orally available, selective COX-2 inhibitors based on 2-imidazoline core. Eur J Med Chem 2014;84:160–72
- Sarnpitak P, Mujumdar P, Taylor P, et al. Panel docking of small-molecule libraries—prospects to improve efficiency of lead compound discovery. Biotechnol Adv 2015;33:941–7
- Schrader FC, Barho M, Steiner I, et al. The antimalarial pipeline – an update. Int J Med Microbiol 2012;302:165–71
- Chhabria M, Patel S, Jani M. Recent development and future perspective of antitubercular therapy. Antiinfect Agents Med Chem 2010;9:59–103
- Welsch ME, Snyder SA, Stockwell BR. Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol 2010;14:347–61
- Kumar D, Khan SI, Tekwani BL, et al. 4-Aminoquinoline-pyrimidine hybrids: synthesis, antimalarial activity, heme binding and docking studies. Eur J Med Chem 2015;89:490–502
- Shibi IG, Aswathy L, Jisha RS, et al. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives. Eur J Pharm Sci 2015;77:9–23
- Keri RS, Patil SA. Quinoline: A promising antitubercular target. Biomed Pharmacother 2014;68:1161–75
- Lilienkampf A, Mao J, Wan B, et al. Structure–activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. J Med Chem 2009;52:2109–18
- Ahirwar S, Shrivastava A, Pathak AK. 2D QSAR study of novel quinoline derivatives as potent antitubercular agents. J Comp Meth Mol Des 2014;4:6–13
- Fujioka H, Murai K, Ohba Y, et al. A mild and efficient one-pot synthesis of 2-dihydroimidazoles from aldehydes. Tetrahedron Lett 2005;46:2197–9
- Martin A, Camacho M, Portaels F, Palomino CC. Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 2003;47:3616–19
- Smilkstein M, Sriwilaijaroen N, Kelly JX, et al. Simple and inexpensive fluorescence-based technique for highthroughput antimalarial drug screening. Antimicrob Agents Chemother 2004;48:1803–6
- Mujumdar P, Grkovic T, Krasavin M. A simple two-step access to diversely substituted imidazo[4,5-b]pyridines and benzimidazoles from readily available 2-imidazolines. Tetrahedron Lett 2013;54:3336–40
- Mujumdar P, Sarnpitak P, Shetnev A, et al. Pd-catalyzed amination of imidazolin-1-yl azines: toward a new kinase-inhibitory chemotype. Tetrahedron Lett 2015;56:2827–31
- Butler RN, Fitzgerald KJ. 12- and 1,3-Diamine exchange between substituted 4,5-dihydroimidazoles and 1,4,5,6-tetrahydropyrimidines: routes to benzimidazoles, dihydroimidazoles, and tetrahydropyrimidines. J Chem Soc Perkin Trans 1989;1:155–7
- Vincent S, Mons S, Lebeau L, Mioskowski C. N,N-Dibenzyl formamidine as a new protective group for primary amines. Tetrahedron Lett 1997;38:7527–30
- Furth PS, Reitman MS, Cook AF. A novel formamidine linker for use in solid-phase synthesis. Tetrahedron Lett 1997;38:5403–6
- Pereira MF, Thiery V, Besson T. Microwave-assisted regioselective N-alkylation of cyclic amidines. Tetrahedron Lett 2007;48:7657–9
- Bhattacharya A, Mishra LC, Sharma M, et al. Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro. Eur J Med Chem 2009;44:3388–93
- Reiter C, Frohlich T, Zeino M, et al. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur J Med Chem 2015;97:164–72
- Kumar A, Srivastava K, Kumar SR, et al. 4Anilinoquinoline triazines: a novel class of hybrid antimalarial agents. Eur J Med Chem 2011;46:676–90
- Gonec T, Bobal P, Sujan J, et al. Investigating the spectrum of biological activity of substituted quinoline-2-carboxamides and their isosteres. Molecules 2012;17:613–44